Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GOSS

Showing results (141-150 of 291) with videos related to

Pageof 30
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 9, 2024
Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysisEliana R Gill, Christopher Dill, Christopher H Goss, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2006
Aggressive prenatal care results in successful fetal outcomes in CF womenEdith Y Cheng, Chris H Goss, Edward F McKone, et al.
Thorax|April 26, 2015
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosisSonya L Heltshe, Christopher H Goss, Valeria Thompson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 22, 2021
C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment responseD R VanDevanter, S L Heltshe, M Skalland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 18, 2020
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatmentD R VanDevanter, S L Heltshe, D B Sanders, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2009
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbationsPatrick A Flume, Peter J Mogayzel, Karen A Robinson, et al.
Cell Reports|July 2, 2013
Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signalingBrian R Shy, Chun-I Wu, Galina F Khramtsova, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2024
Longitudinal changes in BMD in adults with cystic fibrosisReem Jad, Xiayi Ma, Sanja Stanojevic, et al.
Biochimica Et Biophysica Acta|July 20, 1994
Limited proteolysis study of structure-function relationships in Sh I, a polypeptide neurotoxin from a sea anemoneS A Monks, A R Gould, P E Lumley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 26, 2015
Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United StatesKathleen J Ramos, Bradley S Quon, Kevin J Psoter, et al.
Pageof 30

Showing results (141-150 of 291) with videos related to

Sort By:
Pageof 30
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 9, 2024
Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysisEliana R Gill, Christopher Dill, Christopher H Goss, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2006
Aggressive prenatal care results in successful fetal outcomes in CF womenEdith Y Cheng, Chris H Goss, Edward F McKone, et al.
Thorax|April 26, 2015
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosisSonya L Heltshe, Christopher H Goss, Valeria Thompson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 22, 2021
C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment responseD R VanDevanter, S L Heltshe, M Skalland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 18, 2020
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatmentD R VanDevanter, S L Heltshe, D B Sanders, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2009
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbationsPatrick A Flume, Peter J Mogayzel, Karen A Robinson, et al.
Cell Reports|July 2, 2013
Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signalingBrian R Shy, Chun-I Wu, Galina F Khramtsova, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2024
Longitudinal changes in BMD in adults with cystic fibrosisReem Jad, Xiayi Ma, Sanja Stanojevic, et al.
Biochimica Et Biophysica Acta|July 20, 1994
Limited proteolysis study of structure-function relationships in Sh I, a polypeptide neurotoxin from a sea anemoneS A Monks, A R Gould, P E Lumley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 26, 2015
Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United StatesKathleen J Ramos, Bradley S Quon, Kevin J Psoter, et al.
Pageof 30